Landscapes / Companies
Beijing Mabworks Biotech Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials · 9 in all
Trials
8 active
18 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2028Phase 3 trial completes | |||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Neuromyelitis Optica Spectrum Disorder, Lupus Nephritis and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma, Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jun 2028Phase 1/2 trial completes | |||
| Next date | Jun 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Immunoglobulin A Nephropathy | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Non-Hodgkin's Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced or Metastatic Solid Tumor | ||||
| Open drug page | |||||
About
- No active trial
- MBS301, mil60, Recombinant Humanized Monoclonal Antibody MIL93, Recombinant Humanized Monoclonal Antibody MIL95
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021